The frequency of both the action potential-indepencharge transfer in the control group: 99.0% Ϯ 12%; DSI in these two subsets of cells: control, 20.4% Ϯ 3.4%, dent miniature IPSCs (mIPSCs, recorded in the presence of the Na channel blocker tetrodotoxin) and the action n ϭ 8; HT, 32.4% Ϯ 4.3%, n ϭ 8).
The potentiation of DSI could also be observed when potential-dependent sIPSCs (recorded in the absence of tetrodotoxin) was reported to be enhanced in a longlong depolarizing current pulses (5 s, instead of the 500 ms used in the previous experiments) were used to term manner in CA1 cells from HT animals (Chen et al., 1999 (Chen et al., , 2001 ; Figure 1A ). However, the potentiated DSI evoke DSI ( Figure 1C ), indicating that the increase in DSI was present with a wide range of depolarizing stimuli was not simply a consequence of the presence of higher-frequency sIPSCs, since DSI in HT animals was (in fact, the potentiation was present even with a 100 ms pulse, see below). DSI was mediated by cannabinoid significantly larger even when the difference in sIPSC activity was eliminated by comparing a subset of control receptors in both controls and postseizure animals, since the CB1 cannabinoid receptor antagonist cells with the most intense sIPSC activity with a subset of cells from HT animals with the least intense sIPSC SR141716A (SR; 1 M) (Rinaldi-Carmona et al., 1994) abolished DSI in both groups (Figure 1C , inset; DSI in activity (baseline sIPSC charge transfer in this subset of cells from HT animals, expressed as a percent of the SR in control: 0.2% Ϯ 2.3%, n ϭ 4; HT: Ϫ3.5% Ϯ 2.6%, n ϭ 5; additional experiments showed that 0.005% in the presence of the mGluR antagonist LY341495 (200 M, a concentration which blocks all mGluRs; Fitzjohn DMSO, used to dissolve SR, did not change DSI in cells et al., 1998) did not abolish the difference between DSI from either control or HT animals. DSI in DMSO in control measured from control and HT animals (DSI in control: cells: 17.0% Ϯ 4.0%, n ϭ 3; compared to DSI without 10.2% Ϯ 3.7%, n ϭ 7; in HT: 24% Ϯ 4.8%, n ϭ 8; Figure DMSO: 15.6% Ϯ 2.2%, n ϭ 6; DSI in DMSO in cells from 2A, inset; note that the mGluR antagonist decreased HT animals: 35.2% Ϯ 7.5%, n ϭ 4, compared to without DSI in both control and HT groups). Muscarinic receptor DMSO: 34.4% Ϯ 4.6%, n ϭ 6).
activation also enhances endocannabinoid release and Furthermore, DSI was also larger in cells from HT thus potentiates DSI (Kim et al., 2002). However, tonic animals when the experiments were carried out in the increase in acetylcholine levels in the extracellular space absence of carbachol and a short depolarizing pulse could not underlie the observed potentiation of DSI, (100 ms) was used to evoke DSI ( Figure 1D ; under these since DSI in cells from HT animals remained significantly conditions, DSI was small and not significant in controls: larger compared to controls when slices from both 8.2% Ϯ 3.6%, n ϭ 7; but DSI was present in HT: 24.5% Ϯ groups were incubated (Ͼ45 min) in the presence of the 3.2%, n ϭ 9). The potentiation of DSI was persistent, muscarinic receptor antagonist atropine (1 M) (DSI in since it was still present even 5 weeks after seizure controls: 15.3% Ϯ 4.9%, n ϭ 6; DSI in HT: 33.9% Ϯ induction ( Figure 1E ; DSI in control: 15.3% Ϯ 4.8%, n ϭ 5.0%, n ϭ 6; Figure 2A , inset). 10; in HT: 31.9% Ϯ 2.5%, n ϭ 10; note that the enhanceIn the experiments described above, the ligands for ment of DSI was unchanged from 1 week to 5 weeks the CB1 receptors were presumably released from the following the seizures, compare Figures 1B and 1E ).
recorded cells. Therefore, in the next series of experiIn contrast to CA1 pyramidal cells, dentate granule ments we tested the effects of an exogenously applied cells have not been shown to exhibit DSI. Although dencannabinoid agonist. WIN55212-2 (WIN; 5 M) caused tate granule cells in control animals did not show DSI a larger decrease in the amplitude of eIPSCs in cells (DSI in control: Ϫ0.1 Ϯ 3.5, n ϭ 10), significant DSI could from HT animals compared to controls and abolished be observed in these cells 1 week after seizure induction the difference in eIPSCs between the two groups (Figure ( Figure 1F ; DSI in HT: 18.5% Ϯ 3.7%, n ϭ 9; pulse 2B; in the upper panel, eIPSCs were examined in the duration in both the control and HT groups: 5 s), indicatsame cells before and after switching the perfusate to ing that experimental febrile seizures can induce this a solution containing WIN, control: n ϭ 10, HT: n ϭ 10; form of activity-dependent plasticity of the inhibitory additional experiments showed that 0.1% DMSO, used system even in cell types that do not typically exhibit to dissolve WIN, had no significant effect on the ampli-DSI. The DSI observed in granule cells from HT animals tude of the eIPSCs: change in eIPSC amplitude after could be fully blocked by the CB1 receptor antagonist switching the perfusate to a medium containing DMSO, SR (Figure 1F , inset; DSI granule cells from HT animals with respect to the pre-DMSO baseline: 2.7% Ϯ 6.7%, in SR: Ϫ0.8% Ϯ 3.3%, n ϭ 9). n ϭ 4 HT cells; in the lower panel of Figure 2B , the slices In the experiments described above, spontaneous were incubated in control medium or in WIN for 40-60 IPSCs were used to examine the long-term modificamin; control cells without WIN: n ϭ 6; control with WIN: tions in DSI after the seizures. As shown in Figure 2A , DSI n ϭ 6; HT without WIN: n ϭ 7; HT with WIN: n ϭ 7). WIN was also significantly larger when IPSCs were evoked (5 M) had no effect on the eIPSCs in cells from either by electrical stimulation (eIPSCs were elicited by an control or HT animals in the presence of the CB1 antagoelectrode placed near the somatic layer at a constant nist SR (1 M; Figure 2C ; control cells: n ϭ 6; HT: n ϭ distance from the recording electrode, as described in 6). Furthermore, WIN had a larger effect on eIPSCs in the Chen et al., 1999; DSI of eIPSCs in controls: 24.2% Ϯ postseizure animals even 11 weeks after the induction of 5.4%, n ϭ 8; in HT: 40.1% Ϯ 5.5%, n ϭ 10; all experithe seizures ( Figure 2D ; the slices were incubated in 5 ments involving eIPSCs were carried out in the absence M WIN for 30-60 min; control without WIN: n ϭ 10; of carbachol). Therefore, the potentiation of DSI was control with WIN: n ϭ 8; HT without WIN: n ϭ 9; HT with present with both spontaneously occurring and stimula-WIN: n ϭ 5). In order to determine the nature of the presynaptic mechanisms that may be involved in the long-term plasThe results obtained with the exogenous application of the CB1 receptor agonist WIN indicate that the longticity of DSI, the effect of the CB1 receptor antagonist SR (1 M) was tested on eIPSCs. In agreement with lasting potentiation of DSI in CA1 pyramidal cells after hyperthermia-induced seizures is likely to involve a preprevious reports, SR had no effect on the eIPSCs in controls (Hoffman and Lupica, 2000; Wilson and Nicoll, synaptic locus, since an exclusively postsynaptic mechanism alone, e.g., enhanced release of endocannabinoid 2001). However, SR caused a significant increase in the eIPSCs after the seizures ( Figure 3A ; for the results in ligands in response to the same amount of depolarization, cannot explain the fact that exogenous application the lower panel, the slices were incubated either without or with SR for Ͼ30 min; control without SR: n ϭ 6; control of WIN had a larger effect on the eIPSCs after the seizures compared to controls. Moreover, the lack of sensiwith SR: n ϭ 7; HT without SR: n ϭ 7; HT with SR: n ϭ 7; similar results were obtained when the perfusate was tivity of the mIPSCs to cannabinoid receptor activation in cells from animals that had experimental febrile seiswitched to SR during recordings from the same cells, 
induction). SR action).
One possible explanation for the amplitude-enhancAlthough the HPLC/MS assay could not determine the ligand concentration selectively in the extracellular ing effect of the CB1 antagonist on the eIPSCs after the seizures is that there is a tonic activation of CB1 space, these data indicated the lack of a large, sustained change in the total levels of endocannabinoids in the receptors due to increased steady-state levels of the postseizure tissue (additional evidence arguing against slower kinetics of the DSI decay after the seizures was not due to an AM-404-blockable uptake system. These alterations in endocannabinoid release came from the DSE experiments described below).
results were in agreement with our endocannabinoid measurements, indicating that the steady-state levels of endocannabinoids remained unchanged. As reported Potentiation of the Endocannabinoid-Mediated before ( croscopy, based on the dissector sampling method that These electron microscopic results were independently corroborated using a different approach based on is not sensitive to changes in the size of the examined objects (West, 1999 the data from the preembedding immunogold method (compare the data in Figure 6K with Figure 6L ). Taken together, these data showed that the mechanism underlying the enhanced meIPSCs peak amplitude and the increase in CB1 receptor numbers per unit weight of hippocampal tissue (Figures 4I and 4J) was not sprouting of CB1/CCK-positive axons. Since there was no significant sprouting, the increase in the CB1 receptor density detected using Western blots most likely reflected an increase in the number of CB1-positive receptors on the axon terminals of CCK-positive interneurons, in agreement with the electrophysiological data. The increase in CB1 receptors occurred selectively
Discussion

